From: Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
ACT
Dosing regimen (WHO)
ARS-MQ
ARS 4.0 mg/kg and MQ 8.3 mg/kg at 0, 24, 48 h
ART-LF
ART 80.0 mg/kg and LF 480.0 mg/kg at 0, 8, 24, 36, 48, 60 h
DHA-PQ
DHA 4.0 mg/kg and PQ 18.0 mg/kg at 0, 24, 48 h